Analysts Offer Insights on Healthcare Companies: Teladoc (TDOC), Argenx Se (ARGX) and AngioDynamics (ANGO)
AngioDynamics Analyst Ratings
AngioDynamics Analyst Ratings
Buy Rating on AngioDynamics: Growth and Regulatory Approvals Underscore Positive Outlook
AngioDynamics Analyst Ratings
AngioDynamics Stock Upgraded by Oppenheimer on FDA Approval, Strong Balance Sheet
Buy Rating Reaffirmed for AngioDynamics Amidst Strategic Growth and Med-Tech Sector Potential
Analysts' Top Healthcare Picks: AngioDynamics (ANGO), Corcept Therapeutics (CORT)
Raymond James Maintains Outperform on AngioDynamics, Lowers Price Target to $10
AngioDynamics Analyst Ratings
Oppenheimer Keeps Their Hold Rating on AngioDynamics (ANGO)
HC Wainwright & Co. Maintains Buy on AngioDynamics, Lowers Price Target to $18
AngioDynamics Analyst Ratings
Buy Rating Maintained for AngioDynamics Amidst Strategic Restructuring and New Product Launches
Raymond James Maintains Outperform on AngioDynamics, Lowers Price Target to $12
Canaccord Genuity Maintains Buy on AngioDynamics, Lowers Price Target to $17
AngioDynamics Analyst Ratings
HC Wainwright & Co. Maintains Buy on AngioDynamics, Raises Price Target to $20
AngioDynamics Analyst Ratings
Analysts Have Conflicting Sentiments on These Healthcare Companies: AngioDynamics (ANGO), Ionis Pharmaceuticals (IONS) and Akero Therapeutics (AKRO)